DR Cysteamine cysteamine bitartrate: Phase III data

Additionally, the mean total daily, steady-state dose of DR Cysteamine was 82% of patient's incoming dose of Cystagon. There was

Read the full 203 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE